Transcriptomics

Dataset Information

0

Protection against maternal infection-associated fetal growth restriction: proof-of-concept with a microbial-derived immunomodulator


ABSTRACT: Infection-associated inflammatory stress during pregnancy is the most common cause of fetal growth restriction. Treatment strategies for protection of at-risk mothers are limited. Employing mouse models, we demonstrate that oral treatment during pregnancy with a microbial-derived immunomodulator (OM85), markedly reduces risk for fetal loss/growth restriction resulting from maternal challenge with bacterial LPS or influenza. Focusing on LPS exposure, we demonstrate that the key molecular indices of maternal inflammatory stress (RANTES, MIP-1a, CCL2, KC, G-CSF) in gestational tissues/serum, are abrogated by OM85 pretreatment. Systems-level analyses of RNASeq data revealed that OM85 pretreatment selectively tunes LPS-induced activation in maternal gestational tissues for attenuated expression of TNF-, IL1-, and IFNg- driven proinflammatory networks, without constraining Type1-IFN-associated networks central to first-line anti-microbial defense. This study suggests that broad-spectrum protection-of-pregnancy against infection-associated inflammatory stress, without compromising capacity for efficient pathogen eradication, represents an achievable therapeutic goal.

ORGANISM(S): Mus musculus

PROVIDER: GSE85414 | GEO | 2016/10/24

SECONDARY ACCESSION(S): PRJNA338398

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-08-26 | GSE182462 | GEO
2010-01-31 | GSE16207 | GEO
2010-07-01 | E-GEOD-21860 | biostudies-arrayexpress
2012-07-25 | E-GEOD-34058 | biostudies-arrayexpress
2023-04-19 | GSE221665 | GEO
2024-08-31 | GSE270419 | GEO
2009-11-07 | E-GEOD-12730 | biostudies-arrayexpress
2010-02-21 | E-GEOD-16207 | biostudies-arrayexpress
2010-07-02 | GSE21860 | GEO
2019-02-04 | GSE113809 | GEO